baber/WOPTO huggingface dataset:
Patent FI-850297-A0 (FI)
Inventor: WENTZELL JOSEPH M
IPC: B22F9/08
Filed: 1985-01-23
Abstract: An apparatus and a method destined for the production of metal powder, wherein inert gas, especially argon is admixed to a metal melt rising in a riser, thereby forming a metal froth which is pressurized likewise by inert gas, especially argon of high pressure in a pulverization chamber, at the same time, forming metal droplets. These are displaced from the pulverization chamber by the gas blown into the same, to enter an expansion chamber in the form of a collecting vessel, the metal droplets being accelerated in the passage from the pulverization chamber to the collecting vessel, at the same time, forming the finest metal powder.
Patent FI-864791-A0 (FI)
Inventor: TSCHOPP JUERG FRIEDRICH
IPC: C12N15/36
Filed: 1986-11-25
Abstract: Novel DNA constructs comprising regulatory regions plus the structural coding region for hepatitis B surface antigen (HBsAg) are disclosed. The regulatory regions employed are responsive to methanol, non-catabolite repressing carbon sources and catabolite repressing carbon sources followed by carbon source starvation. The novel constructs are incorporated into a variety of linear and circular plasmids. Such plasmids are used to transform suitable hosts and ultimately used for the production and isolation of hepatitis B surface antigen in high yields.
Patent FI-883151-A0 (FI)
Inventor: BERTOLA MAURO ATTILIO
IPC: C12P17/00
Filed: 1988-07-01
Abstract: A process is provided for the enrichment in R isomer of an aryloxypropionic acid ester and for the stereoselective hydrolysis of an aryloxypropionic acid ester to form the corresponding aryloxypropionic acid in predominantly S configuration which comprises subjecting an aryloxypropionic acid ester of formula I <CHEM> wherein A is an ester residue and preferably an alkyl group, optionally substituted or branched, wherein R min  is an optionally substituted aryl or heterocyclic ring system, containing in addition to carbon atoms one or more atoms selected from nitrogen, sulphur and oxygen, this ring system being optionally substituted and wherein B and D are for example a hydrogen or a halogen atom, to the action of a microorganism or substance derived thereof capable of stereoselective hydrolysis of the COOA group to form the corresponding carboxylic acid predominantly is S configuration.
Patent FI-893805-A0 (FI)
Inventor: BREIVIK HARALD
IPC: A61K38/00
Filed: 1989-08-11
Abstract: Fatty acid composition comprising at least 80% by weight of omega-3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be used for the treatment or prophylaxis of multiple risk factors for cardiovascular diseases.
Patent FI-895109-A0 (FI)
Inventor: SCHIRLIN DANIEL
IPC: A61K38/55
Filed: 1989-10-27
Abstract: This invention relates to novel analogs of certain peptidase substrates in which the nitrogen atom of the scissile amide bond has been replaced with difluoro-methylene moiety and in which the carbonyl moiety of its adjacent amide bond has been replaced with a terminal amine function, said novel analogs having the property of inhibiting renin and which are useful in the treatment of hypertension. The novel analogs correspond to the formula <CHEM> b
Patent FI-903153-A0 (FI)
Inventor: CLEVE ARWED
IPC: C07J43/00
Filed: 1990-06-21
Abstract: Compounds of the general formula I have been described <IMAGE> in which X, R<1>, R<2>, R<3> and R<4> have the meaning stated in the description, as well as processes for the preparation thereof, pharmaceutical products containing these compounds, and the use thereof for the treatment of diseases. The compounds have, in particular, antigestagenic and antiglucocorticoid activity.
Patent FI-911447-A0 (FI)
Inventor: UCKUN FATIH M
IPC: A61K47/48
Filed: 1991-03-25
Abstract: Pokeweed antiviral protein (PAP) - monoclonal antibody conjugates capable of inhibiting virus replication in mammalian cells without detectable cytotoxicity are provided.
Patent FI-915191-A0 (FI)
Inventor: DIETZ HANS
IPC: B27B31/08
Filed: 1991-11-04
Abstract: A device serves for cleaving or slitting preferably wood. It has a narrow tool, in particular a circular saw blade (15), which possesses cutting elements and produces a gap of finite width in the sawn article (10). The tool and the sawn article (10) are moved in a feed direction (30) relative to one another. A cleaving element (20) is arranged directly behind the cutting elements in the feed direction (30) of the sawn article (10). A profiled piece (12) separated from a sawn-article remainder (13) by the gap is thus bent out of the gap plane (11) away from the sawn-article remainder (13). A deflecting device (27, 28) is arranged at a first distance (L1) from the cleaving element (20) and exerts a force (F1) on the surface (44) of the profiled piece (12) facing away from the gap plane (11). A supporting device (40 to 42) is arranged at a second distance (L2) from the cleaving element (20) which is smaller than the first distance (L1). The supporting device (40 to 42) exerts a force (F2) on the surface (45) of the profiled piece (12) facing the gap plane (11) (Fig. 2). 
<IMAGE>
Patent FI-924216-A0 (FI)
Inventor: WESTON TERENCE EDWARD
IPC: A61M11/02
Filed: 1992-09-21
Abstract: A metered dose inhaler comprises a piston (3) which is mounted in a cavity (2) within a body (1), and is urged by a pre-loaded spring (6) into a reduced cross-section pressure chamber (4). The piston (3) may be loaded by means of an actuating rod (31) having a handle (32), and may be latched in a loaded position by a latching means (33). A liquid drug (e.g. in aqueous solution) is contained in a collapsible bag (10). Metered quantities of the drug are successively presented in the pressure chamber (4), and then subjected to a sudden and great increase in pressure, to eject the liquid drug through an atomising head (22), to reduce it to a fine atomised spray of small mean particle size - for example, less than 30 micrometres. Non-return valves (13 and 23) control the flow of liquid through the device. The sudden pressure pulse is caused by releasing the spring loaded piston (3), upon depressing an actuating button (35) connected to the latching means (33). <IMAGE>
Patent FI-941882-A0 (FI)
Inventor: KNIGHT MALCOM ROBERT MURRAY
IPC: D21F1/44
Filed: 1994-04-22
Abstract: This invention relates to a method of making sheet materials and security paper having partially embedded therein an elongate security element which is at least substantially exposed at one surface of the sheet at a plurality of spaced locations, which method comprises the steps of depositing fibres onto a moving support surface, supplying an elongate security element to overlie rotatable embedment means, which embedment means comprise a plurality of spaced-apart raised portions having recesses therebetween, introducing the security element into the fibres with rotation of the embedment means such that some fibres move into said recesses between the security element and the embedment means so that said security element is covered by fibres, and substantially preventing fibres from penetrating between the raised portions and the overlying security element.
Patent FI-942897-A0 (FI)
Inventor: HERZIG CHRISTIAN
IPC: C07F7/12
Filed: 1994-06-17
Abstract: PCT No. PCT/EP92/02932 Sec. 371 Date Jun. 8, 1994 Sec. 102(e) Date Jun. 8, 1994 PCT Filed Dec. 17, 1992 PCT Pub. No. WO93/13110 PCT Pub. Date Jul. 8, 1993.The invention concerns iodonium salts of the general formula A-I+-B X-, in which A is a group of the general formula    <IMAGE>  (1)  in which C is a monovalent aromatic hydrocarbon group with 6 to 14 carbon atoms or a monovalent aromatic hydrocarbon group containing at least one oxygen and/or sulphur atom and with 5 to 14 atoms in the aromatic ring, D, E and F are each substituents of C, D being a group of the formula -(O)x-(R)y-SiR1/3, E being a group of the formula -OR2, F being a group of the formula -R3, a being 1, 2, or 3, b being 0, 1 or 2, c being 0, 1 or 2, x being 0 or 1 and y being 0 or 1, and R, R1, R2 and R3 are as defined in claim 1; B is a group of the formula    <IMAGE>  (2)  in which E and F, which are as defined above, may each be bound to the 2, 3, 4, 5 or 6 position in the benzene ring, d is 0, 1 or 2, e is 0, 1 or 2 and X- is a tosylate anion or a weakly nucleophilic or non-nucleophilic anion Y- selected from the group comprising CF3CO2-, BF4-, PF4-, AsF6-, SbF6-, ClO4-, HSO4- and CF3SO3-.
Patent FI-943620-A0 (FI)
Inventor: EHROLA JUHA
IPC: D21G1/02
Filed: 1994-08-04
Abstract: The invention concerns a variable-crown roll loaded by means of shoes, comprising a stationary roll axle (12), around which a tubular roll mantle (11) is fitted revolving, which roll mantle is mounted by its ends on the roll axle (12) by means of end bearings (13a,13b). Hydraulic loading shoes (151...15n) are fitted between the roll mantle (11) and the roll axle (12), which shoes act upon the inner face of the roll mantle (11) in the nip plane and are supported on the roll axle (12) and which shoes are loaded by means of a hydraulic pressure medium, and the nip pressure can be profiled in the axial direction of the roll (10) by regulating the pressure of the pressure medium passed into said loading shoes. The roll mantle (11) is made of a fibre-reinforced composite material so that the stability of shape of the roll mantle (11) in the direction of the circumference is good and the rigidity in the axial direction is low. <MATH>
Patent FI-950134-A0 (FI)
Inventor: WAETTERBAECK PAUL GUNNAR
IPC: F16B/
Filed: 1995-01-11
Abstract: PCT No. PCT/SE92/00519 Sec. 371 Date May 16, 1995 Sec. 102(e) Date May 16, 1995 PCT Filed Jul. 15, 1992 PCT Pub. No. WO94/02749 PCT Pub. Date Feb. 3, 1994A torque nut or screw that allows the nut to be tightened to a preset maximum torque, but prevents excess tightening. The nut or screw includes inner and outer threaded elements that extend along the same axis. The outer threaded element is tapered with respect to the axis. The fastener includes an inner fastening member (7) having fastening threads (8) and an outer female member (10) that is rotatable by means of a spanner, a pair of pliers, a screw driver, or other tool. The female member is connected to the inner fastening member by a coupling (13) having a sufficient strength to transfer to the inner fastening member a torque of a magnitude for which the fastening device is designed. The outer female member (10) is designed to be released upon tightening of the coupling and rotated relative to the inner fastening member (7), but not until the predetermined torque is exceeded. The coupling between the outer female (10) and the inner fastening member (7) includes a conical screw coupling.
Patent FI-952115-A0 (FI)
Inventor: HORSTMANN MICHAEL
IPC: A61K/
Filed: 1995-05-03
Abstract: The invention concerns a transdermal therapeutic system comprising the active substance 17- beta -estradiol and optionally further active substances, with a laminated structure comprising a backing layer which is substantially impermeable to moisture and impermeable to active substance, one or more matrix layers and, where non-adhesive matrix layers are present, an adhesive layer, characterized in that the concentration of the dissolved estradiol in all matrix layers and, where an adhesive layer is present, in the adhesive layer lies between its saturation concentration in dry condition und its saturation concentration in moist condition, whereby the term "dry condition" is understood to mean that the base material is in equilibrium with a gas phase with less than 10% relative humidity and the term "moist condition" is understood to mean that the base material is in equilibrium with a gas phase with more than 90% relative humidity.
Patent FI-963239-A0 (FI)
Inventor: LAGNEMO HANS
IPC: C07C59/285
Filed: 1996-08-19
Abstract: PCT No. PCT/SE94/00943 Sec. 371 Date Aug. 23, 1996 Sec. 102(e) Date Aug. 23, 1996 PCT Filed Oct. 7, 1994 PCT Pub. No. WO95/23208 PCT Pub. Date Aug. 31, 1995The invention relates to particles having a core comprising a peroxy compound with capability of releasing hydrogen peroxide or peroxy acids in aqueous solutions, which particles have a coating containing alkali metal silicate and a chelating agent. The invention also relates to preparation and use of the particles as well as a composition containing such particles.
Patent FI-972189-A0 (FI)
Inventor: BOWDEN MARTIN CHARLES
IPC: C07C69/65
Filed: 1997-05-22
Abstract: The invention provides novel compounds of formula:CF3-CXCl-CH(OH)CH2-C(CH3)2-CH2-CO2R(I)where X represents chloro or bromo and R represents hydrogen or alkyl of up to 4 carbon atoms, processes for preparing them and their use as intermediates in the preparation of insecticidal cyclopropane derivatives. Also provided are novel compounds of formula:BrCH2-CH2-C(CH3)2-CH2-CO2R(IV)wherein R represents alkyl of up to 4 carbon atoms, useful as intermediates in the preparation of the compounds of formula I.
Patent IL-71650-A0 (IL)
Title: Treatment of seizure disorders and pharmaceutical compositions useful therein
IPC: A61K31/24
Filed: 1984-04-26
Abstract: Glycine, sarcosine, or N,N-dimethylglycine exerts a synergistic effect upon gamma-vinyl GABA for the treatment of seizure disorders, in particular epilepsy.
Patent IL-78945-A0 (IL)
Title: Device for detecting the variation of thickness of a fabric and method of calibrating it
IPC: D05B35/10
Filed: 1986-05-27
Abstract: A device for detecting a thickness variation of a piece of fabric passing under the presser foot of a sewing machine. The device includes a transmitter and receiver between which the fabric passes. The receiver stores maximum and minimum signals in memory units generated when the fabric passes between the transmitter and receiver. A computing unit calibrates the thresholds as a function of the stored maximum and minimum signals. A comparator compares the incoming signals with the calibrated thresholds and sends a signal to a logic unit to control the sewing operations accordingly.
Patent IL-88472-A0 (IL)
Title: Mammalian interleukin-1 receptor protein dnas and expression vectors encoding them,processes for producing them and pharmaceutical compositions containing them
IPC: C07K14/52
Filed: 1988-11-24
Abstract: Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.
Patent IL-89092-A0 (IL)
Title: Carbon fibrils
IPC: C04B35/622
Filed: 1989-01-27
Abstract: The invention relates to a volume of carbone fibrils that includes a multiplicity of fibrils (10) having a morphology consisting of vermicular tubes that are free of a continuous thermal carbon overcoat and have the graphite layers (12) that are substantially parallel to the fibril axis (16) and a process for preparing such fibrils.
Patent IL-90206-A0 (IL)
Title: Pharmaceutical compositions for reducing the side effects of tnf
IPC: A61P35/00
Filed: 1989-05-05
Abstract: Concomitant administration of TNFs with a PAF antagonist allows the unwanted side effects of the TNFs to be reduced and the therapeutic index of the TNFs to be increased.
Patent IL-91901-A0 (IL)
Title: Production of liposomes with improved stability during drying
IPC: A61K9/127
Filed: 1989-10-05
Abstract: A composition and method are provided for the making of cholesterol containing phospholipid liposomes such that when dried and then reconstituted, the liposomes retain their structure and size distribution as well as substantially all of the material that was originally encapsulated, and they behave biologically in a normal fashion. The cryoprotective agents are used in the aqueous medium to hydrate the phospholipid(s) and are a combination of at least one sugar and at least one protein, polypeptide, and/or oligopeptide.
Patent IL-95152-A0 (IL)
Title: Substituted aminoalkoxybenzene derivatives,their manufacture and pharmaceutical compositions containing them
IPC: C07D295/092
Filed: 1990-07-23
Abstract: The compound of the formula   <IMAGE> I  wherein each of R1 and R2 individually is hydrogen, lower alkyl or lower alkenyl or together signify straight-chain alkylene with 2 or 4 carbon atoms, R3 is hydrogen, halogen or lower alkyl, Q is alkylene with 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies or alkenylene with 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies and each of Y and Y' individually is a direct bond or the group -CH2-, -CH2CH2-, -CH=CH- or -C 3BOND C-, the group R1R2N-Q-O- is attached to the 3- or 4-position of ring A and the symbol R designates that the ring to which it is attached is unsubstituted or is substituted with at least one substituent selected from the group consisting of halogen, trifluoromethyl, cyano, nitro, lower alkyl and lower alkoxy, and their pharmaceutically acceptable acid addition salts can be used for the control or prevention of fungal infections, especially of topical or systemic infections which are caused by pathogenic fungi, and for the manufacture of antifungally-active medicaments. The compounds of formula I have not only a pronounced antifungal activity, but they also exhibit synergistic effects in combination with other known antifungally-active substances which inhibit sterol biosynthesis such as ketoconazole and terbinafine.
Patent IL-96043-A0 (IL)
Title: Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
IPC: C07K19/00
Filed: 1990-10-17
Abstract: Antibody to a polypeptide is provided, in which the polypeptide is complementary to at least a portion of a peptide ligand and characterised by said antibody having an affinity for a receptor site at which the peptide ligand binds and transmits its hormonal effects.
Patent IL-97276-A0 (IL)
Title: Process for the preparation of(2r,3r)-cis-beta-phenylglycidic acid
IPC: C07D303/48
Filed: 1991-02-19
Abstract: PCT No. PCT/FR91/00133 Sec. 371 Date Aug. 21, 1992 Sec. 102(e) Date Aug. 21, 1992 PCT Filed Feb. 20, 1991 PCT Pub. No. WO91/13066 PCT Pub. Date Sep. 5, 1991.A method for preparing  beta -phenylglycidic-(2R, 3R) acid optionally in the form of salt or ester by precipitation of the salt of the  beta -phenylglycidic-(2R,3R) acid with (+)- alpha -methylbenzylamine-(R) in a solution of a mixture of salts of cis and trans  beta -phenylglycidic acids with (+)- alpha -methylbenzylamine(R)- and the use of the resulting product for preparing taxol and its analogs.
Patent AU-PQ485399-A0 (AU)
Title: Heat treatment of age-hardenable aluminium alloys
IPC: C22F1/00
Filed: 1999-12-23
Abstract: The heat treatment of an age-hardenable aluminium alloy, having alloying elements in solid solution includes the stages of holding the alloy for a relatively short time at an elevated temperature T<SUB>A </SUB>appropriate for ageing the alloy; cooling the alloy from the temperature T<SUB>A </SUB>at a sufficiently rapid rate and to a lower temperature so that primary precipitation of solute elements is substantially arrested; holding the alloy at a temperature T<SUB>B </SUB>for a time sufficient to achieve a suitable level of secondary nucleation or continuing precipitation of solute elements; and heating the alloy to a temperature which is at, sufficiently close to, or higher than temperature T<SUB>A </SUB>and holding for a further sufficient period of time at temperature T<SUB>C </SUB>for achieving substantially maximum strength.
Patent FI-20002891-A0 (FI)
Inventor: KONTKANEN PETRI TAPANI
IPC: H04W64/00
Filed: 2000-12-29
Abstract: A method for estimating a receiver's location in a wireless communication environment having several channels. Each channel has at least one signal parameter that varies with location differently from the other channels. A set of calibration data is determined for each calibration point, each set including the location and at least one measured signal parameter for each of several channels. The calibration data serve as a basis for a statistical model of the signal parameters versus a receiver's location. A set of observed signal parameters is determined, the set including at least one signal parameter for each of several channels at the receiver's location. A location estimate approximating the location of the receiver is determined on the basis of the statistical model and the set of observed signal parameters.
Patent FI-20040653-A0 (FI)
Inventor: PERRET MARKUS
IPC: B65D71/70
Filed: 2004-05-07
Abstract: This publication discloses a bottle tray (1) for single bottles and bottles bundled into a multipack package, such as a multipack package comprising bottles in at least two parallel rows and a carrier/sleeve enclosing the bottles, the top surface of the bottle tray (1) having thereon bottle pockets (2) in at least two parallel rows to accommodate bottles in a multipack and first support members (3) for supporting the multipack laterally from two opposite sides, and the bottom of the bottle tray (1) being provided with support surfaces (5, 6) for supporting the bottle tray (1) to bottles underlying the bottle tray (1). Second support members (4) are provided on the top surface of the bottle tray (1) for supporting bottles placed in the pockets (2), whereby the second support members (4) are adapted into the spaces between the parallel rows of pockets formed between the first support members (3) and have a height smaller than that of the first support members (3). <IMAGE>
Patent FI-20060397-A0 (FI)
IPC: B01L/
Filed: 2006-04-25
Abstract: This invention relates to a method for selecting a plunger-cylinder tip of a pipette and a device for carrying out the method. In the method, the dose size is entered into the control electronics of the pipetting device; the dose size is stored in the control electronics; the amount of doses is entered; and on the basis of the dose size and the amount of doses, the control electronics indicates suitable available interchangeable components on the display.
Patent IL-104125-A0 (IL)
Title: Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
IPC: A61P25/04
Filed: 1992-12-17
Abstract: PCT No. PCT/US92/10743 Sec. 371 Date Jun. 15, 1994 Sec. 102(e) Date Jun. 15, 1994 PCT Filed Dec. 17, 1992.Disclosed is a compound of Formula I:    <IMAGE>  (I)  or a pharmaceutically acceptable salt or solvate thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a Compound of Formula I. Further disclosed is a method of treating allergy (for example asthma), inflammation, hypertension, raised intraocular pressure (such as glaucoma)-i.e., a method of lowering intraocular pressure, sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract, hypo and hyperactivity of the central nervous system (for example, agitation and depression) and other CNS disorders (such as Alzheimers, Schizophrenia, and migraine) comprising administering an effective amount of a compound of Formula I to a patient in need of such treatment.
Patent IL-108184-A0 (IL)
Title: Use of disulfonyl methanes for the control of parasites
IPC: C07C317/14
Filed: 1993-12-27
Abstract: The present invention is directed to the use of disulfonyl methane compounds for the control of parasites in vertebrate animals.
Patent IL-110913-A0 (IL)
Title: Method and apparatus for early embryonic in ovo injection
IPC: A61K45/00
Filed: 1994-09-09
Abstract: An apparatus for administering compounds to avian eggs through the shell thereof comprises a blocking member, an elongate shaft connected to the blocking member, an active agent depot connected to the elongate shaft, and an adhesive seal connected to the blocking member for sealably connecting the blocking member to the egg shell with the shaft penetrating through the shell. Methods of using the apparatus of the present invention are also described.